GlassScriptPhysician profile
Melissa Jacobs
NPI 1114239100
$10,220.84
in general payments reported to CMS, 2019-2025
56 companies · $1,309 in 2025
The $1,309 reported for 2025 was more than what 85% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,448 · 2022: $2,027 · 2023: $2,219 · 2024: $1,219 · 2025: $1,309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,742 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,741.80 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,381.15 | 2021 | |
| Abbvie INC. | $1,324.84 | 2021-2025 | |
| Novo Nordisk INC | $660.90 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $459.15 | 2021-2024 | Mounjaro, Jardiance, Trulicity |
| Dexcom, INC. | $429.26 | 2021-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $388.77 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $357.15 | 2021-2024 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $346.45 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Amarin Pharma, INC. | $342.56 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $273.77 | 2024-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $273.74 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $252.28 | 2021-2024 | Jardiance, Jentadueto Xr, Synjardy |
| Amgen INC. | $239.16 | 2021-2024 | Repatha, Otezla |
| Sanofi-Aventis U.S. LLC | $235.33 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $233.92 | 2021-2023 | Trintellix |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $228.83 | 2022 | |
| Janssen Pharmaceuticals, INC | $188.89 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $181.30 | 2024-2025 | Prolaris |
| Antares Pharma, INC. | $170.95 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $168.72 | 2021-2025 | Xtandi |
| Endo USA, INC. | $162.25 | 2024-2025 | Xiaflex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.12 | 2021-2024 | Trulance, Xifaxan |
| Phathom Pharmaceuticals, INC. | $127.04 | 2025 | Voquezna |
| Ironwood Pharmaceuticals, INC | $124.61 | 2021-2023 | Linzess |
| 180 Medical, INC. | $120.09 | 2024-2025 | Gentlecath Glide |
| Radius Health, INC. | $105.78 | 2021-2024 | Tymlos |
| Procept Biorobotics Corporation | $101.61 | 2025 | |
| Mylan Specialty L.P. | $81.36 | 2023 | Yupelri |
| Esperion Therapeutics, INC. | $76.34 | 2021-2023 | Nexletol |
| Exact Sciences Corporation | $74.90 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $73.58 | 2022-2023 | |
| Eisai INC. | $73.14 | 2021 | |
| Idorsia Pharmaceuticals US INC | $72.71 | 2023 | Quviviq |
| Teleflex LLC | $69.90 | 2025 | Urolift |
| Inspire Medical Systems, INC. | $67.27 | 2024-2025 | Inspire |
| Abbott Laboratories | $56.07 | 2022-2023 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $52.23 | 2022-2024 | Rexulti |
| Bioprotect Medical, INC. | $49.18 | 2025 | Bioprotect Balloon Implant System |
| Kowa Pharmaceuticals America, INC. | $47.09 | 2022-2023 | Livalo, Seglentis |
| Tris Pharma INC | $45.20 | 2023 | Dyanavel Xr |
| Medtronic, INC. | $37.05 | 2024 | Symplicity G3 |
| Corium, LLC | $35.52 | 2022-2023 | Azstarys |
| Axsome Therapeutics, INC. | $31.69 | 2023 | Auvelity |
| Alnylam Pharmaceuticals INC. | $29.14 | 2024 | Onpattro |
| Janssen Biotech, INC. | $27.45 | 2025 | Erleada |
| Boston Scientific Corporation | $24.58 | 2025 | Rezum Generator |
| Azurity Pharmaceuticals, INC. | $24.15 | 2025 | Azmiro |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.82 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $19.58 | 2022 | |
| Ethicon US, LLC | $17.31 | 2024 | Vistaseal, Stratafix |
| Sanofi Pasteur INC. | $17.05 | 2022 | |
| Uc-Care (USA), INC | $16.56 | 2025 | Navigo Workstation |
| Endo Pharmaceuticals INC. | $15.76 | 2021 | |
| Lundbeck LLC | $15.72 | 2024 | Rexulti |
| Scilex Pharmaceuticals INC. | $15.14 | 2024 | |
| Acerus Pharmaceuticals Corporation | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.